Sarah Roden


Topeka Capital Sees Ad Potential in IAC’s Mobile App, Tinder

IAC/InterActiveCorp (NASDAQ: IACI) focuses on the areas of search, applications, online dating, media and e-Commerce. One of the most popular mobile applications among teenagers …

Intel Earnings Break Records but Reports Weak Guidance

Intel (NASDAQ: INTC) released fourth quarter and fiscal-year earnings for 2014 on January 15th. The report precipitated mixed ratings as the company broke revenue …

Will Netflix’s Q4 Report Pull the Company out of Its Slump?

Netflix (NASDAQ: NFLX) is expected to report fourth quarter earnings on Tuesday, January 20th after market close. The Golden Globes put all doubts aside regarding …

New Facebook Platforms Excite Investors

Facebook (NASDAQ: FB), Silicon Valley’s golden child, never ceases to impress the public with clever innovations. Most recently, the social media giant has announced …

IBM to Restructure in Order to Focus on Cloud Computing

IBM (NYSE: IBM) is undergoing a massive structural reorganization under the leadership of CEO Ginny Rometty in order to parallel the rise in cloud …

SanDisk Lowers Q4 Estimates

SanDisk (NASDAQ: SNDK) shares plunged yesterday, January 12th, when the semiconductor company lowered estimates for their fourth quarter earnings. SanDisk had previously forecasted revenue …

Analysts Make Bullish Ratings in Response to Valeant’s Increased 2015 Guidance

Valeant Pharmaceuticals (NYSE: VRX) held a conference call with investors on Thursday, January 8th, in which the company increased its guidance for 2015. Initially, …

Agenus Prices Spike after Partnership with Incyte

Agenus, Inc (NASDAQ: AGEN) announced a global alliance with Incyte Corp. (NASDAQ: INCY) to develop cancer therapies.

Google’s Search Engine Contract with Apple is Coming to an End

Google (NASDAQ: GOOGL) and Apple (NASDAQ: AAPL) are hegemonic and competing companies whose healthy rivalry fuels innovation. However, what happens when Apple has the upper …

Does Cempra Have The Next Blockbuster Drug?

Pharmaceutical company Cempra (NASDAQ: CEMP) creates antibiotics to treat bacterial infections. The company produces Solithromycin, a treatment for community-acquired bacterial pneumonia that is now …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts